Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for 89bio, Inc. Common Stock, par value $0.001 per share (ETNB).
- Disclosed ownership: 3.6%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 3.6% ownership in 89bio, Inc. Common Stock, par value $0.001 per share (ETNB) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 1.9% | 2,227,427 | 0 | 2,227,427 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 1.9% | 2,227,427 | 0 | 2,227,427 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 1.5% | 1,799,517 | 0 | 1,799,517 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 1.5% | 1,799,517 | 0 | 1,799,517 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.2% | 223,979 | 0 | 223,979 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.2% | 223,979 | 0 | 223,979 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 3.4% | 4,026,944 | 0 | 4,026,944 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 3.6% | 4,333,885 | 0 | 4,333,885 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 3.6% | 4,333,885 | 0 | 4,333,885 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 3.6% | 4,333,885 | 0 | 4,333,885 | /s/ Mark N. Lampert | Mark N. Lampert |